Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

256640-45-6

256640-45-6 structure

256640-45-6 structure

Name: J-113397
Chemical Name: J-113397
CAS Number: 256640-45-6
Molecular Formula: C₂₄H₃₇N₃O₂
Molecular Weight: 399.57
Catalog: Signaling Pathways GPCR/G Protein Opioid Receptor
Create Date: 2023-04-05 10:27:59
Modify Date: 2024-07-05 18:09:18
J-113397 is the first potent and selective nonpeptidyl ORL1 receptor antagonist (Ki: cloned human ORL1=1.8 nM) without any agonistic effects on other opioid receptors[1].

Name	J-113397

Description	J-113397 is the first potent and selective nonpeptidyl ORL1 receptor antagonist (Ki: cloned human ORL1=1.8 nM) without any agonistic effects on other opioid receptors[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Opioid Receptor Signaling Pathways >> Neuronal Signaling >> Opioid Receptor Research Areas >> Neurological Disease
Target	NOP Receptor/ORL1:1.8 ± 0.24 nM (Ki) κ Opioid Receptor/KOR:640 ± 87 nM (Ki) μ Opioid Receptor/MOR:1000 ± 160 nM (Ki) δ Opioid Receptor/DOR:>10000 nM (Ki)
In Vitro	J-113397 (0-500 nM) inhibits NociceptinNociceptin/orphanin FQ (HY-P0183)-stimulated [35S]GTPγS binding to CHO cells expressing ORL1 (CHO-ORL1) but had no effect on [35S]GTPγS binding by itself[1]. Cell Viability Assay[1] Cell Line: CHO-ORL1 cells Concentration: 0, 0.1, 1, 10, 100, 200, 500 nM Incubation Time: 10 min Result: Inhibited nociceptin/orphanin FQ-stimulated [35S]guanosine 5′-O-(γ-thio)triphosphate (GTPγS) binding to Chinese Hamster Ovary (CHO) cells expressing ORL1 (CHO-ORL1) with an IC50 value of 5.3 nM but had no effect on [35S]GTPγS binding by itself.
In Vivo	J-113397 (0-30 mg/kg; subcutaneously (s.c.); once) dose-dependently inhibits hyperalgesia elicited by intracerebroventricular (i.c.v.) administration of NociceptinNociceptin/orphanin FQ (HY-P0183) in a tail-flick test with mice[1]. Animal Model: Male ICR mice (15–25 g)[1] Dosage: 0, 3, 10, 30 mg/kg Administration: Subcutaneously (s.c.), 10 min prior to administering 0.1 nmol nociceptin/orphanin FQ to the mice Result: Dose-dependently inhibited hyperalgesia elicited by intracerebroventricular (i.c.v.) administration of nociceptin/orphanin FQ in a tail-flick test with mice.
References	[1]. Ozaki S, et al. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur J Pharmacol. 2000 Aug 18;402(1-2):45-53.

Molecular Formula	C₂₄H₃₇N₃O₂
Molecular Weight	399.57

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.